Bellerophon Therapeutics, Inc. (NASDAQ:BLPH – Get Free Report) declared a dividend on Tuesday, December 17th,investing.com reports. Investors of record on Friday, December 20th will be given a dividend of 0.019 per share by the biotechnology company on Wednesday, December 18th. This represents a yield of 117.8%. The ex-dividend date of this dividend is Thursday, December 19th.
Bellerophon Therapeutics Stock Performance
Shares of BLPH opened at $0.02 on Tuesday. Bellerophon Therapeutics has a twelve month low of $0.01 and a twelve month high of $0.02. The firm’s 50 day moving average price is $0.04 and its two-hundred day moving average price is $0.04. The firm has a market cap of $196,951.30, a P/E ratio of -0.02 and a beta of 0.74.
Wall Street Analysts Forecast Growth
Separately, StockNews.com initiated coverage on shares of Bellerophon Therapeutics in a report on Tuesday, December 10th. They issued a “hold” rating on the stock.
About Bellerophon Therapeutics
Bellerophon Therapeutics, Inc, a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its primary product is INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension.
See Also
- Five stocks we like better than Bellerophon Therapeutics
- 3 Grocery Stocks That Are Proving They Are Still Essential
- These 3 Stocks Look to Power AI Data Centers With Natural Gas
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Shift Into Growth: Top 3 Hybrid Vehicle Makers to Invest In
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Top 3 Cutting-Edge Micro-Caps Set for 2025 Growth
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
